Aurinia Pharmaceuticals
Manufacturing · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
14315-118 Avenue 140, Edmonton, Alberta,...Phone Number
(250) 744-2487Website
www.auriniapharma.comRevenue
$298.3 MillionStock Symbol
AUPHIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
1
1
1
1
About Aurinia Pharmaceuticals
Aurinia Pharmaceuticals a clinical-stage biopharmaceutical company develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis.Explore more
Aurinia Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aurinia Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Aurinia Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Aurinia Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Aurinia Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Aurinia Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Aurinia Pharmaceuticals
Check out if Aurinia Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when Aurinia Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Aurinia Pharmaceuticals has new funding data
Recommended Actions
Reach out to Masked Content who joined Aurinia Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Aurinia Pharmaceuticals
Compare insights from companies similar to Aurinia Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aurinia Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aurinia Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals Tech Stack
A closer look at the technologies used by Aurinia Pharmaceuticals
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
New Hire
Executive Move
Executive Moves, New Hire
Person-Based
Aurinia Pharmaceuticals News & Media
Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcript
Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call June 3, 2026 12:00 PM EDTCompany ParticipantsKevin Tang - Chairman & CEOStephen P.Aurinia Pharmaceuticals Inc. Appoints Michael Hearne as Chief Financial Officer
Aurinia Pharmaceuticals Inc. has appointed Michael Hearne as Chief Financial Officer....Aurinia Pharmaceuticals (AUPH) Reports Financial Results for Three and Twelve Months Ended December 31, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is one of the best cheap biotech stocks to buy now. Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) reported financial results for the three and twelve months ended December 31, 2025, on February 26, 2026. It reported that total revenue for the three and twelve months was $77.1 million and $283.1 million, up 29% […]
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Aurinia Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Aurinia Pharmaceuticals a clinical-stage biopharmaceutical company develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis.... Read More
